Literature DB >> 20821129

Differentiation of hepatic tumors by use of image contrast with T2-weighted MRI.

Akio Ogura1, Katsumi Hayakawa, Tosiaki Miyati, Fumie Maeda, Akira Miyai, Fumito Saeki, Takaharu Murata.   

Abstract

Differentiation of hepatic tumors is often evaluated in terms of qualitative diagnostic performance. The signal intensity patterns of hepatic masses are known to differ on certain T2-weighted imaging sequences. In this study, we investigated the quantitative analysis of hepatic masses by using an index called the "T2-shine ratio." Fast-spin-echo (FSE), half-Fourier acquisition single-shot turbo spin echo (HASTE), and true-FISP sequences obtained with quick-imaging techniques during a single breath-hold were examined in 74 patients. T2-shine ratios were calculated by use of the signals of regions of interest (ROIs) placed on a tumor and peripheral tissue: the T2-shine ratio is defined as (tumor signal-liver signal)/liver signal. The rate of change in the T2-shine ratio was compared among three sequences of FSE, HASTE, and true-FISP. The T2-shine ratio of FSE deducted from HASTE was significantly higher for hepatic cysts than for other masses. The T2-shine ratio of HASTE deducted from True-FISP was less than zero for hemangioma. For the value that deducted the T2-shine ratio of HASTE from the T2-shine ratio of true-FISP, hemangiomas had a significantly lower value than did cysts and metastases (P < 0.05), but there was no significant difference from hepatocellular carcinomas (HCCs). Although liver cysts, cavernous hemangiomas, and other lesions could be differentiated, it was virtually impossible to distinguish HCCs from metastatic tumors. In conclusion, the quantitative analysis of hepatic tumors was able to differentiate among these lesions by use of the T2-shine ratio.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20821129     DOI: 10.1007/s12194-008-0043-0

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  13 in total

1.  Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.

Authors:  K Mori; H Yoshioka; Y Itai; Y Okamoto; H Mori; N Takahashi; Y Saida
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

2.  Distinguishing hepatic metastases from hemangiomas: qualitative and quantitative diagnostic performance through dual echo respiratory-triggered fast spin echo magnetic resonance imaging.

Authors:  Young H Kim; Sanjay Saini; Michael A Blake; Mukesh Harisinghani; Yi-You Chiou; Won Jin Lee; Jeong-Sik Yu; Peter F Hahn
Journal:  J Comput Assist Tomogr       Date:  2005 Sep-Oct       Impact factor: 1.826

3.  Hepatic tumors: dynamic MR imaging.

Authors:  K Ohtomo; Y Itai; K Yoshikawa; T Kokubo; N Yashiro; M Iio; K Furukawa
Journal:  Radiology       Date:  1987-04       Impact factor: 11.105

4.  MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions.

Authors:  C Poeckler-Schoeniger; J Koepke; F Gueckel; J Sturm; M Georgi
Journal:  Magn Reson Imaging       Date:  1999-04       Impact factor: 2.546

5.  Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging.

Authors:  K Ohtomo; Y Itai; S Furui; N Yashiro; K Yoshikawa; M Iio
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

6.  Differentiation between hemangiomas and cysts of the liver with nonenhanced MR imaging: efficacy of T2 values at 1.5 T.

Authors:  W Li; M A Nissenbaum; M K Stehling; A Goldmann; R R Edelman
Journal:  J Magn Reson Imaging       Date:  1993 Sep-Oct       Impact factor: 4.813

7.  Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging.

Authors:  E G McFarland; W W Mayo-Smith; S Saini; P F Hahn; M A Goldberg; M J Lee
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

8.  Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.

Authors:  T J Vogl; R Hammerstingl; W Schwarz; M G Mack; P K Müller; W Pegios; H Keck; A Eibl-Eibesfeldt; J Hoelzl; B Woessmer; C Bergman; R Felix
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

9.  Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.

Authors:  Seishi Kumano; Takamichi Murakami; Tonsok Kim; Masatoshi Hori; Atsuya Okada; Takashi Sugiura; Yumi Noguchi; Syuji Kawata; Kaname Tomoda; Hironobu Nakamura
Journal:  AJR Am J Roentgenol       Date:  2003-11       Impact factor: 3.959

10.  Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.

Authors:  Ali S Arbab; Tomoaki Ichikawa; Hironobu Sou; Tsutomu Araki; Hiroto Nakajima; Keiichi Ishigame; Takeharu Yoshikawa; Hiroshi Kumagai
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

View more
  1 in total

1.  Characterization of soft tissue masses: can quantitative diffusion weighted imaging reliably distinguish cysts from solid masses?

Authors:  Ty K Subhawong; Daniel J Durand; Gaurav K Thawait; Michael A Jacobs; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2013-08-24       Impact factor: 2.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.